Major histocompatibility complex (MHC) class I KbDb--/--deficient mice possess functional CD8+ T cells and natural killer cells

被引:104
|
作者
Vugmeyster, Y
Glas, R
Pérarnau, B
Lemonnier, FA
Eisen, H
Ploegh, H
机构
[1] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
[2] Inst Pasteur, Unite Immunite Cellulaire Antivirale, Paris, France
[3] MIT, Ctr Canc Res, Cambridge, MA 02142 USA
关键词
D O I
10.1073/pnas.95.21.12492
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
We obtained mice deficient for major histocompatibility complex (MHC) molecules encoded by the H-2K and H-2D genes. H-2 (KDb)-D-b -/- mice express no detectable classical MHC class I-region associated (Ta) heavy chains, although Pz-microglobulin and the nonclassical class Ib proteins examined are expressed normally. (KDb)-D-b -/- mice have greatly reduced numbers of mature CD8+ T cells, indicating that selection of the vast majority (>90%) of CD8+ T cells cannot be compensated for by beta(2)-microglobulin-associated molecules other than classical H-2K and D locus products. In accord with the greatly reduced number of CD8+ T cells, spleen cells from KbDb -/- mice do not generate cytotoxic responses in primary mixed-lymphocyte cultures against MHC-disparate (allogeneic) cells. However, in vivo priming of (KDb)-D-b -/- mice with allogeneic cells resulted in strong CD8+ MHC class Ia-specific allogeneic responses. Thus, a minor population of functionally competent peripheral CD8+ T cells capable of strong cytotoxic activity arises in the complete absence of classical MHC class Ia molecules. (KDb)-D-b -/- animals also have natural killer cells that retain their cytotoxic potential.
引用
收藏
页码:12492 / 12497
页数:6
相关论文
共 50 条
  • [21] CD8+ T cell killing of MHC class I–deficient tumors
    Christopher E. Rudd
    Nature Cancer, 2023, 4 : 1214 - 1216
  • [22] MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I-SPECIFIC AND CLASS-I-RESTRICTED KILLING OF BETA(2)-MICROGLOBULIN-DEFICIENT CELLS BY CD8+ CYTOTOXIC LYMPHOCYTES-T
    GLAS, R
    FRANKSSON, L
    OHLEN, C
    HOGLUND, P
    KOLLER, B
    LJUNGGREN, HG
    KARRE, K
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (23) : 11381 - 11385
  • [23] αβTCR+ cells are a minimal fraction of peripheral CD8+ pool in MHC class I-deficient mice
    Nesic, D
    Santori, FR
    Vukmanovic, S
    JOURNAL OF IMMUNOLOGY, 2000, 165 (04): : 1896 - 1901
  • [24] Role of MHC class I and CD8+ T cells in the pathogenesis of chronic rejection
    Sun, H
    Subbotin, V
    Woodward, J
    Valdivia, L
    Fung, JJ
    Rao, AS
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (1-2) : 319 - 319
  • [25] DEPLETION OF CD4+ T-CELLS IN MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II DEFICIENT MICE
    GRUSBY, MJ
    JOHNSON, RS
    PAPAIOANNOU, VE
    GLIMCHER, LH
    SCIENCE, 1991, 253 (5026) : 1417 - 1420
  • [26] INCREASED NUMBER OF CYTOTOXIC T-CELLS WITHIN CD4+8- T-CELLS IN BETA(2)-MICROGLOBULIN, MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I-DEFICIENT MICE
    MARUSICGALESIC, S
    UDAKA, K
    WALDEN, P
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (12) : 3115 - 3119
  • [27] Cross-reactivity of cytomegalovirus-specific CD8+ T cells to allo-major histocompatibility complex class I molecules
    Gamadia, LE
    Remmerswaal, EB
    Surachno, S
    Lardy, NM
    Wertheim-van Dillen, PM
    van Lier, RAW
    Ten Berge, IJM
    TRANSPLANTATION, 2004, 77 (12) : 1879 - 1885
  • [28] A role for major histocompatibility complex (MHC) class II molecules in MHC class I presentation and CD8 T cell priming
    Belizaire, Roger
    Rohrs, Henry
    Suri, Anish
    Unanue, Emil
    FASEB JOURNAL, 2008, 22
  • [29] ANTIGEN-SPECIFIC RECOGNITION BY CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTED T-CELLS AND ACTIVATION OF CD8+ MEMORY CYTOTOXIC T-CELLS
    KOS, FJ
    CANADIAN JOURNAL OF MICROBIOLOGY, 1993, 39 (02) : 141 - 157
  • [30] Major histocompatibility complex class I and tumour immuno-evasion: how to fool T cells and natural killer cells at one time
    Fruci, D.
    Benevolo, M.
    Cifaldi, L.
    Lorenzi, S.
    Lo Monaco, E.
    Tremante, E.
    Giacomini, P.
    CURRENT ONCOLOGY, 2012, 19 (01) : 39 - 41